EA200100069A1 - Новые 19-норстероиды, галогенированные в положении 17, способ их получения и их применение, промежуточные продукты и фармацевтические композиции, их содержащие - Google Patents

Новые 19-норстероиды, галогенированные в положении 17, способ их получения и их применение, промежуточные продукты и фармацевтические композиции, их содержащие

Info

Publication number
EA200100069A1
EA200100069A1 EA200100069A EA200100069A EA200100069A1 EA 200100069 A1 EA200100069 A1 EA 200100069A1 EA 200100069 A EA200100069 A EA 200100069A EA 200100069 A EA200100069 A EA 200100069A EA 200100069 A1 EA200100069 A1 EA 200100069A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
intermediate products
norsteroid
halogenated
reception
Prior art date
Application number
EA200100069A
Other languages
English (en)
Other versions
EA003325B1 (ru
Inventor
Йасмина Буали
Жак Може
Франсуа Ник
Патрик Ван Де Вельд
Original Assignee
Хехст Марион Руссель
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хехст Марион Руссель filed Critical Хехст Марион Руссель
Publication of EA200100069A1 publication Critical patent/EA200100069A1/ru
Publication of EA003325B1 publication Critical patent/EA003325B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Предметом изобретения являются соединения общей формулы (I), в которой, в частности, X = галоген, Y = простая связь, O, NH, S, SO или SO; Z = водород или галоген; n, R, R, Rи Rтакие, как определенные в описании, способ их получения и промежуточные продукты, их применение в качестве лекарств и фармацевтические композиции, их содержащие.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200100069A 1998-06-23 1999-06-22 19-норстероиды, галогенированные в положении 17, способы их получения и их применение, промежуточные продукты и фармацевтические композиции, их содержащие EA003325B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9807898A FR2780060B1 (fr) 1998-06-23 1998-06-23 Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
PCT/FR1999/001491 WO1999067274A1 (fr) 1998-06-23 1999-06-22 Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
EA200100069A1 true EA200100069A1 (ru) 2001-06-25
EA003325B1 EA003325B1 (ru) 2003-04-24

Family

ID=9527717

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100069A EA003325B1 (ru) 1998-06-23 1999-06-22 19-норстероиды, галогенированные в положении 17, способы их получения и их применение, промежуточные продукты и фармацевтические композиции, их содержащие

Country Status (37)

Country Link
US (2) US6423700B1 (ru)
EP (1) EP1090027B1 (ru)
JP (1) JP4509380B2 (ru)
KR (1) KR20010034919A (ru)
CN (1) CN1313862A (ru)
AP (1) AP1579A (ru)
AR (1) AR018916A1 (ru)
AT (1) ATE237628T1 (ru)
AU (1) AU771369B2 (ru)
BR (1) BR9912206A (ru)
CA (1) CA2336167A1 (ru)
CZ (1) CZ296246B6 (ru)
DE (1) DE69906972T2 (ru)
DK (1) DK1090027T3 (ru)
DZ (1) DZ2827A1 (ru)
EA (1) EA003325B1 (ru)
ES (1) ES2196879T3 (ru)
FR (1) FR2780060B1 (ru)
HK (1) HK1039945A1 (ru)
HR (1) HRP20000893A2 (ru)
HU (1) HUP0103194A3 (ru)
ID (1) ID27410A (ru)
IL (1) IL140416A (ru)
MA (1) MA26656A1 (ru)
MY (1) MY118101A (ru)
NO (1) NO318381B1 (ru)
NZ (1) NZ508535A (ru)
PL (1) PL345073A1 (ru)
PT (1) PT1090027E (ru)
SK (1) SK19492000A3 (ru)
TN (1) TNSN99130A1 (ru)
TR (1) TR200003857T2 (ru)
TW (1) TW550077B (ru)
UA (1) UA66867C2 (ru)
WO (1) WO1999067274A1 (ru)
YU (1) YU80700A (ru)
ZA (1) ZA200007355B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3922104B2 (ja) * 2002-06-07 2007-05-30 富士通株式会社 ポイント管理装置、ポイント管理システム、ポイント管理方法、およびポイント管理プログラム
FR2854402B1 (fr) * 2003-04-29 2008-07-04 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
FR2854403B1 (fr) 2003-04-29 2008-07-11 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides 17-halogenes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3079408A (en) * 1963-02-26 Ig-bisoxygenated iy-haloestra-
US3264327A (en) * 1962-07-27 1966-08-02 Syntex Corp 17alpha-fluoro-, 17beta-chlorofluoroacetoxy- and 17beta-methyl-delta4-and delta5-androstene derivatives
US3413321A (en) * 1966-06-03 1968-11-26 Du Pont Selected 17-fluoro-delta16 steroids
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2761992B1 (fr) * 1997-04-09 1999-06-11 Hoechst Marion Roussel Inc Nouveaux steroides 4-halogenes, leur procede et intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2771096B1 (fr) * 1997-11-17 2000-08-11 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides, substitues en position 11beta, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
US6566542B2 (en) 2003-05-20
ID27410A (id) 2001-04-05
PT1090027E (pt) 2003-09-30
HUP0103194A3 (en) 2002-09-30
CN1313862A (zh) 2001-09-19
SK19492000A3 (sk) 2001-09-11
MY118101A (en) 2004-08-30
AP1579A (en) 2006-02-22
BR9912206A (pt) 2001-04-10
US20030022874A1 (en) 2003-01-30
YU80700A (sh) 2003-10-31
FR2780060B1 (fr) 2000-08-04
AR018916A1 (es) 2001-12-12
DE69906972T2 (de) 2004-02-05
UA66867C2 (ru) 2004-06-15
CZ20004834A3 (en) 2001-06-13
NO318381B1 (no) 2005-03-14
NO20006573L (no) 2001-02-22
PL345073A1 (en) 2001-12-03
WO1999067274A1 (fr) 1999-12-29
JP4509380B2 (ja) 2010-07-21
AU771369B2 (en) 2004-03-18
IL140416A (en) 2005-07-25
MA26656A1 (fr) 2004-12-20
DK1090027T3 (da) 2003-08-04
EP1090027A1 (fr) 2001-04-11
DE69906972D1 (de) 2003-05-22
HRP20000893A2 (en) 2001-10-31
HUP0103194A2 (hu) 2002-01-28
KR20010034919A (ko) 2001-04-25
AU4270599A (en) 2000-01-10
ES2196879T3 (es) 2003-12-16
HK1039945A1 (zh) 2002-05-17
TR200003857T2 (tr) 2001-06-21
ZA200007355B (en) 2001-12-11
JP2002518516A (ja) 2002-06-25
IL140416A0 (en) 2002-02-10
ATE237628T1 (de) 2003-05-15
TW550077B (en) 2003-09-01
DZ2827A1 (fr) 2003-12-01
AP2000002007A0 (en) 2000-12-31
FR2780060A1 (fr) 1999-12-24
NO20006573D0 (no) 2000-12-21
NZ508535A (en) 2002-08-28
CA2336167A1 (fr) 1999-12-29
TNSN99130A1 (fr) 2005-11-10
EP1090027B1 (fr) 2003-04-16
EA003325B1 (ru) 2003-04-24
CZ296246B6 (cs) 2006-02-15
US6423700B1 (en) 2002-07-23

Similar Documents

Publication Publication Date Title
EA200400432A1 (ru) Производные мочевины
PL366198A1 (en) Novel compounds
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
HK1048990A1 (en) Novel compounds.
YU149791A (sh) Mometason, furoat monohidrat i postupak za njegovo dobijanje
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
IL94915A0 (en) Substituted quinazolinones and pharmaceutical compositions containing them
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
AU2003228770A8 (en) Substituted pyrazolopyrimidines
IL135536A0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
CA2338600A1 (en) Novel thiazolopyrimidine compounds
PL306084A1 (en) Novel compound and method of obtaining them as well as pharmaceutic agent containing such compounds
EA200200479A1 (ru) Новые олигосахариды, их получение и содержащие их фармацевтические композиции
CR6540A (es) Trifluorobutenos nematicidas
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
EA199900621A1 (ru) Лечение рассеянного склероза путем приема внутрь или ингаляции сополимера-1
EA200100516A1 (ru) Производные 3,3-биарилпиперидина и 2,2-биарилморфолина
SE0101038D0 (sv) Novel compounds
PT1427417E (pt) Derivados de 6, 7-di-hidroxitetra-hidroisoquinolina substituída em 3 para utilização como agentes antibacterianos
SE9802574D0 (sv) Novel compounds
DE60201074D1 (en) Pyrazolopyridinderivate
SE9904128D0 (sv) Novel compounds
EA199700223A1 (ru) Бициклические антагонисты тахикининов, их получение и применение в фармацевтической композиции
EA200100069A1 (ru) Новые 19-норстероиды, галогенированные в положении 17, способ их получения и их применение, промежуточные продукты и фармацевтические композиции, их содержащие
EA200000530A1 (ru) НОВЫЕ 19-НОРСТЕРОИДЫ, ЗАМЕЩЕННЫЕ В ПОЛОЖЕНИИ 11β, СПОСОБ И ПРОМЕЖУТОЧНЫЕ ПРОДУКТЫ ДЛЯ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ

Legal Events

Date Code Title Description
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title